Pasteurella multocida toxin

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 430-447

  Wilson, Brenda A ^a   Ho, Mengfei ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548435506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50027-5     Document Type: Chapter

References (188)

1. Ackermann M.R., Register K.B., Stabel J.R., Gwaltney S.M., Howe T.S., Rimler R.B. Effect of Pasteurella multocida toxin on physeal growth in young pigs. Am. J. Vet. Res. 1996, 57:848-852.
2. q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 1998, 95:10140-10145.
3. Adler B., Bulach D., Chung J., Doughty S., Hunt M., Rajakumar K., Serrano M., van Zanden A., Zhang Y., Ruffolo C. Candidate vaccine antigens and genes in Pasteurella multocida. J. Biotechnol. 1999, 73:83-90.
4. Aepfelbacher M., Essler M. Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: a role for Rho/Rho kinase. Cell Microbiol. 2001, 3:649-658.
5. Andresen L.O. Undersogelser over Pasteurella multocida DNA. Pavisning af et mobiliserbart DNA-element indeholdende PMT-genet i P. multocida's kromosom. Danish Acad. Techn. Scienc., Erhvervsforskerrapport, EF 1989, 229.
6. Bagley K.C., Abdelwahab S.F., Tuskan R.G., Lewis G.K. Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists. Clin. Diagn. Lab. Immunol. 2004, 11:77-82.
7. Baldwin M.R., Lakey J.H., Lax A.J. Identification and characterization of the Pasteurella multocida toxin translocation domain. Mol. Microbiol. 2004, 54:239-250.
8. Baldwin M.R., Pullinger G.D., Lax A.J. Pasteurella multocida toxin facilitates inositol phosphate formation by bombesin through tyrosine phosphorylation of G alpha q. J. Biol. Chem. 2003, 278:32719-32725.
9. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature 1993, 361:315-325.
10. q/11, and phospholipase Cβ-1. J. Biol. Chem. 1992, 267:8081-8088.
11. Bording A., Foged N.T. Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin. Vet. Microbiol. 1991, 29:267-280.
12. Brockmeier S.L., Palmer M.V., Bolin S.R., Rimler R.B. Effects of intranasal inoculation with Bordetella bronchiseptica, porcine reproductive, and respiratory syndrome virus, or a combination of both organisms on subsequent infection with Pasteurella multocida in pigs. Am. J. Vet. Res. 2001, 62:521-525.
13. Buetow L., Flatau G., Chiu K., Boquet P., Ghosh P. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat. Struct. Biol. 2001, 8:584-588.
14. Bunemann M., Meyer T., Pott L., Hosey M. Novel inhibition of Gβγ-activated potassium currents induced by M(2) muscarinic receptors via a pertussis toxin-insensitive pathway. J. Biol. Chem. 2000, 275:12537-12545.
15. Busch C., Orth J., Djouder N., Aktories K. Biological activity of a C-terminal fragment of Pasteurella multocida toxin. Infect. Immun. 2001, 69:3628-3634.
16. Buys W.E., Smith H.E., Kamps A.M., Kamp E.M., Smits M.A. Sequence of the dermonecrotic toxin of Pasteurella multocida ssp. multocida. Nucleic Acids Res. 1990, 18:2815-2816.
17. Camps M., Carozzi A., Schnabel P., Scheer A., Parker P.J., Gierschik P. Isozyme-selective stimulation of phospholipase C&2 by G protein βγ-subunits. Nature 1992, 360:684-686.
18. Chanter N. Advances in atrophic rhinitis and toxigenic Pasteurella multocida research. Pig News Inform. 1990, 11:503-506.
19. Chanter N., Magyar T., Rutter J.M. Interactions between Bordetella bronchiseptica and toxigenic Pasteurella multocida in atrophic rhinitis of pigs. Res. Vet. Sci. 1989, 47:48-53.
20. Chanter N., Rutter J.M. Colonization by Pasteurella multocida in atrophic rhinitis of pigs and immunity to the osteolytic toxin. Vet. Microbiol. 1990, 25:253-265.
21. Chanter N., Rutter J.M., Mackenzie A. Partial purification of an osteolytic toxin from Pasteurella multocida. J. Gen. Microbiol. 1986, 132:1089-1097.
22. Cheville N.F., Rimler R.B. A protein toxin from Pasteurella multocida type D causes acute and chronic hepatic toxicity in rats. Vet. Pathol. 1989, 26:148-157.
23. Cheville N.F., Rimler R.B., Thurston J.R. A toxin from Pasteurella multocida type D causes acute hepatic necrosis in pigs. Vet. Pathol. 1988, 25:518-520.
24. q-coupled receptors. J. Biol. Chem. 2002, 277:27130-27134.
25. Chrisp C.E., Foged N.T. Induction of pneumonia in rabbits by use of a purified protein toxin from Pasteurella multocida. Am. J. Vet. Res. 1991, 52:56-61.
26. Davies R.L., MacCorquodale R., Baillie S., Caffrey B. Characterization and comparison of Pasteurella multocida strains associated with porcine pneumonia and atrophic rhinitis. J. Med. Microbiol. 2003, 52:59-67.
27. Davies R.L., MacCorquodale R., Reilly S. Characterization of bovine strains of Pasteurella multocida and comparison with isolates of avian, ovine, and porcine origin. Vet. Microbiol. 2004, 99:145-158.
28. de Jong M.F., Akkermans J.P. Investigation into the pathogenesis of atrophic rhinitis in pigs. I Atrophic rhinitis caused by Bordetella bronchiseptica and Pasteurella multocida and the meaning of a thermolabile toxin of P. multocida. Vet. Quarterly 1986, 8:204-214.
29. de Jong M.F., de Wachter J.C., de Marel G.M. Investigation into the pathogenesis of atrophic rhinitis in pigs. II. AR induction and protection after intramuscular injections cell-free filtrates and emulsions containing AR toxin of Pasteurella multocida. Vet. Quarterly 1986, 8:215-224.
30. Deeb B.J., DiGiacomo R.F. Respiratory diseases of rabbits. Vet. Clinics North America. Exotic Animal Practice 2000, 3:465-480.
31. Deeb B.J., DiGiacomo R.F., Bernard B.L., Silbernagel S.M. Pasteurella multocida and Bordetella bronchiseptica infections in rabbits. J. Clin. Microbiol. 1990, 28:70-75.
32. DiGiacomo R.F., Deeb B.J., Brodie S.J., Zimmerman T.E., Veltkamp E.R., Chrisp C.E. Toxin production by Pasteurella multocida isolated from rabbits with atrophic rhinitis. Am. J. Vet. Res. 1993, 54:1280-1286.
33. DiGiacomo R.F., Deeb B.J., Giddens W.E., Bernard B.L., Chengappa M.M. Atrophic rhinitis in New Zealand white rabbits infected with Pasteurella multocida. Am. J. Vet. Res. 1989, 50:1460-1465.
34. DiGiacomo R.F., Garlinghouse L.E., Van Hoosier G.L. Natural history of infection with Pasteuella multocida in rabbits. J. Am. Vet. Med. Assoc. 1983, 183:1172-1175.
35. DiGiacomo R.F., Taylor F.G., Allen V., Hinton M.H. Naturally acquired Pasteurella multocida infection in rabbits: immunological aspects. Lab. Animal Sci. 1990, 40:289-292.
36. DiGiacomo R.F., Xu Y.M., Allen V., Hinton M.H., Pearson G.R. Naturally acquired Pasteurella multocida infection in rabbits: clinicopathological aspects. Can. J. Vet. Res. 1991, 55:234-238.
37. Dominick M.A., Rimler R.B. Turbinate atrophy in gnotobiotic pigs intranasally inoculated with protein toxin isolated from type D Pasteurella multocida. Am. J. Vet. Res. 1986, 47:1532-1536.
38. Dominick M.A., Rimler R.B. Turbinate osteoporosis in pigs following intranasal inoculation of purified Pasteurella toxin: histomorphometric and ultrastructural studies. Vet. Pathol. 1988, 25:17-27.
39. Donald A.N., Wallace D.J., McKenzie S., Marley P.D. Phospholipase C-mediated signaling is not required for histamine-induced catecholamine secretion from bovine chromaffin cells. J. Neurochem. 2002, 81:1116-1129.
40. Dowling A., Hodgson J.C., Dagleish M.P., Eckersall P.D., Sales J. Pathophysiological and immune cell responses in calves prior to and following lung challenge with formalin-killed Pasteurella multocida biotype A:3 and protection studies involving subsequent homologous live challenge. Vet. Immunol. Immunopathol. 2004, 100:197-207.
41. Dowling A., Hodgson J.C., Schock A., Donachie W., Eckersall P.D., McKendrick I.J. Experimental induction of pneumonic pasteurellosis in calves by intratracheal infection with Pasteurella multocida biotype A:3. Res. Vet. Sci. 2002, 73:37-44.
42. Dudet L.I., Chailler P., Dubreuil J.D., Martineau-Doize B. Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts. J. Cell Physiol. 1996, 168:173-182.
43. q family members induce Rho GTPase activation and Rhodependent actin filament assembly. FEBS Lett. 2002, 531:565-569.
44. Elias B., Boros G., Albert M., Tuboly S., Gergely P., Papp L., Barna Vetro I., Rafai P., Molnar E. Clinical and pathological effects of the dermonecrotic toxin of Bordetella bronchiseptica and Pasteurella multocida in specific-pathogen-free piglets. Nippon Juigaku Zasshi-Jap. J. Vet. Sci. 1990, 52:677-688.
45. Elias B., Gergely P., Boros G., Varro R. Epizootiological studies on porcine atrophic rhinitis. X. Study of the heat-labile exotoxin (HLT) of Pasteurella multocida in mice. Acta Veterinaria Hungarica 1986, 34:137-143.
46. Elling F., Pedersen K.B. The pathogenesis of persistent turbinate atrophy induced by toxigenic Pasteurella multocida in pigs. Vet. Pathol. 1985, 22:469-474.
47. Elling F., Pedersen K.B., Hogh P., Foged N.T. Characterization of the dermal lesions induced by a purified protein from toxigenic Pasteurella multocida. APMIS 1988, 96:50-55.
48. Essler M., Hermann K., Amano M., Kaibuchi K., Heesemann J., Weber P.C., Aepfelbacher M. Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J. Immunol. 1998, 161:5640-5646.
49. Fabbri A., Gauthier M., Boquet P. The 5′ region of cnf1 harbors a translational regulatory mechanism for CNF1 synthesis and encodes the cell-binding domain of the toxin. Mol. Microbiol. 1999, 33:108-118.
50. Falbo V., Pace T., Picci L., Pizzi E., Caprioli A. Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli. Infect. Immun. 1993, 61:4909-4914.
51. Falzano L., Fiorentini C., Donelli G., Michel E., Kocks C., Cossart P., Cabanie L., Oswald E., Boquet P. Induction of phagocytic behavior in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol. Microbiol. 1993, 9:1247-1254.
52. Felix R., Fleisch H., Frandsen P.L. Effect of Pasteurella multocida toxin on bone resorption in vitro. Infect. Immun. 1992, 60:4984-4988.
53. Fiorentini C., Fabbri A., Flatau G., Donelli G., Matarrese P., Lemichez E., Falzano L., Boquet P. Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the Rho GTPase. J. Biol. Chem. 1997, 272:19532-19537.
54. Fiorentini C., Falzano L., Fabbri A., Stringaro A., Logozzi M., Travaglione S., Contamin S., Arancia G., Malorni W., Fais S. Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells. Mol. Biol. Cell 2001, 12:2061-2073.
55. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., Boquet P. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997, 387:729-733.
56. Foged N.T. Quantitation and purification of the Pasteurella multocida toxin by using monoclonal antibodies. Infect. Immun. 1988, 56:1901-1906.
57. Foged N.T. Detection of stable epitopes on formaldehyde-detoxified Pasteurella multocida toxin by monoclonal antibodies. Vaccine 1991, 9:817-824.
58. Foged N.T. Pasteurella multocida toxin. The characterization of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS Suppl. 1992, 25:1-56.
59. Foged N.T., Nielsen J.P., Jorsal S.E. Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies. Vet. Record 1989, 125:7-11.
60. Foged N.T., Pedersen K.B., Elling F. Characterization and biological effects of the Pasteurella multocida toxin. FEMS Microbiol. Lett. 1987, 43:45-51.
61. Frymus T., Muller E., Franz B., Petzoldt K. Protection by toxoid-induced antibody of gnotobiotic piglets challenged with the dermonecrotic toxin of Pasteurella multocida. Zentralblatt Fuer Veterinaermedizin Reihe B 1989, 36:674-680.
62. Fukuhara S., Murga C., Zohar M., Igishi T., Gutkind J.S. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J. Biol. Chem. 1999, 274:5868-5879.
63. Gillette M.U., Buchanan G.F., Artinian L., Hamilton S.E., Nathanson N.M., Liu C. Role of the M1 receptor in regulating circadian rhythms. Life Sci. 2001, 68:2467-2472.
64. Gosau N., Fahimi-Vahid M., Michalek C., Schmidt M., Wieland T. Signaling components involved in the coupling of alpha(1)-adrenoceptors to phospholipase D in neonatal rat cardiac myocytes. Naunyn Schmiedebergs Arch. Pharmacol. 2002, 365:468-476.
65. Gratacap M.P., Payrastre B., Nieswandt B., Offermanns S. Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. J. Biol. Chem. 2001, 276:47906-47913.
66. Gwaltney S.M., Galvin R.J., Register K.B., Rimler R.B., Ackermann M.R. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts. Vet. Pathol. 1997, 34:421-430.
67. Hamilton T.D., Roe J.M., Hayes C.M., Webster A.J. Effect of ovalbumin aerosol exposure on colonization of the porcine upper airway by Pasteurella multocida and effect of colonization on subsequent immune function. Clin. Diagn. Lab. Immunol. 1998, 5:494-498.
68. Harmey D., Stenbeck G., Nobes C.D., Lax A.J., Grigoriadis A.E. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): A role for Rho GTPase in bone formation. J. Bone Mineral Res. 2004, 19:661-670.
69. Harris D.L., Switzer W.P. Turbinate atrophy in young pigs exposed to Bordetella bronchiseptica, Pasteurella multocida, and combined inoculum. Am. J. Vet. Res. 1968, 29:777-785.
70. 13. Science 1998, 280:2112-2114.
71. Higgins T.E., Murphy A.C., Staddon J.M., Lax A.J., Rozengurt E. Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth. Proc. Natl. Acad. Sci. USA 1992, 89:4240-4244.
72. Horiguchi Y. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Toxicon 2001, 39:1619-1627.
73. Horiguchi Y., Inoue N., Masuda M., Kashimoto T., Katahira J., Sugimoto N., Matsuda M. Bordetella bronchiseptica dermonecrotizing toxin induces reorganization of actin stress fibers through deamidation of Gln-63 of the GTP-binding protein Rho. Proc. Natl. Acad. Sci. USA 1997, 94:11623-11626.
74. Horiguchi Y., Senda T., Sugimoto N., Katahira J., Matsuda M. Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stresss fibers and focal adhesions by modifying the small GTP-binding protein Rho. J. Cell Sci. 1995, 108:3243-3251.
75. Horiguchi Y., Sugimoto N., Matsuda M. Stimulation of DNA synthesis in osteoblast-like MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin. Infect. Immun. 1993, 61:3611-3615.
76. Hoskins I.C., Lax A.J. Constitutive expression of Pasteurella multocida toxin. FEMS Microbiol. Lett. 1996, 141:189-193.
77. iDali C., Foged N.T., Frandsen P.L., Nielsen M.H., Elling F. Ultrastructural localization of the Pasteurella multocida toxin in a toxin-producing strain. J. Gen. Microbiol. 1991, 137:1067-1071.
78. Il'ima Z.M., Zasukhin M. Role of Pasteurella toxins in the pathogenesis of infectious atrophic rhinitis. Sb. Nauchn. Rab. Sib. Nauchn. Issled. Inst. Omsk 1975, 25:76-86.
79. Jarvinen L.Z., Hogenesch H., Suckow M.A., Bowersock T.L. Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxinand potassium thiocyanate extract. Infect. Immun. 1998, 66:3788-3795.
80. Jordan R.W., Hamilton T.D., Hayes C.M., Patel D., Jones P.H., Roe J.M., Williams N.A. Modulation of the humoral immune response of swine and mice mediated by toxigenic Pasteurella multocida. FEMS Immunol. Med. Microbiol. 2003, 39:51-59.
81. Jordan R.W., Roe J.M. An experimental mouse model of progressive atrophic rhinitis of swine. Vet. Microbiol. 2004, 103:201-207.
82. Jutras I., Martineau-Doize B. Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures. Can. J. Vet. Res. 1996, 60:34-39.
83. Kamp E.M., Kimman T.G. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida, as well as bacterium-free crude and purified dermonecrotictoxin of P. multocida. Am. J. Vet. Res. 1988, 49:1844-1849.
84. Kamp E.M., Popma J.K., Van Leengoed L.A. Serotyping of Hemophilus pleuropneumoniae in the Netherlands: with emphasis on heterogeneity within serotype 1 and (proposed) serotype 9. Vet. Microbiol. 1987, 13:249-257.
85. Kamps A.M., Kamp E.M., Smits M.A. Cloning and expression of the dermonecrotic toxin gene of Pasteurella multocida ssp. multocida in Escherichia coli. FEMS Microbiol. Lett. 1990, 55:187-190.
86. q induce Rho-dependent neurite retraction through different signaling pathways. J. Biol. Chem. 1998, 273:28700-28707.
87. Kielstein P. On the occurrence of toxin-producing Pasteurella multocida strains in atrophic rhinitis and in pneumonias of swine and cattle. Zentralblatt Fuer Veterinaermedizin Reihe B 1986, 33:418-424.
88. Kielstein P., Elias B. Zur Bedeutung von Bordetella bronchiseptica und Pasteurella multocida bei der Rhinitis atrophicans suum. Zentralblatt Fuer Veterinaermedizin Reihe B 1985, 32:694-705.
89. Kimman T.G., Lowik C.W., van de Wee-Pals L.J., Thesingh C.W., Defize P., Kamp E.M., Bijvoet O.L. Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxincontaining conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida. Infect. Immun. 1987, 55:2110-2116.
90. 13. Science 1998, 280:2109-2111.
91. 13 as key regulatory mediator in signal transduction. Life Sci. 2003, 74:155-161.
92. FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J. Biol. Chem. 1996, 271:439-445.
93. Lacerda H.M., Pullinger G.D., Lax A.J., Rozengurt E. Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(Rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells. J. Biol. Chem. 1997, 272:9587-9596.
94. Lax A.J., Chanter N. Cloning of the toxin gene from Pasteurella multocida and its role in atrophic rhinitis. J. Gen. Microbiol. 1990, 136:81-87.
95. Lax A.J., Chanter N., Pullinger G.D., Higgins T., Staddon J.M., Rozengurt E. Sequence analysis of the potent mitogenic toxin of Pasteurella multocida. FEBS Lett. 1990, 277:59-64.
96. Lax A.J., Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002, 10:293-299.
97. q family subunits, phospholipase C, and a readily diffusible messenger. J. Biol. Chem. 2001, 276:16720-16730.
98. Lemichez E., Flatau G., Bruzzone M., Boquet P., Gauthier M. Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol. Microbiol. 1997, 24:1061-1070.
99. Lockman H.A., Gillespie R.A., Baker B.D., Shakhnovich E. Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect. Immun. 2002, 70:2708-2714.
100. Magyar T., Chanter N., Lax A.J., Rutter J.M., Hall G.A. The pathogenesis of turbinate atrophy in pigs caused by Bordetella bronchiseptica. Vet. Microbiol. 1988, 18:135-146.
101. Magyar T., King V.L., Kovacs F. Evaluation of vaccines for atrophic rhinitis-a comparison of three challenge models. Vaccine 2002, 20:1797-1802.
102. Martineau-Doize B., Caya I., Gagne S., Jutras I., Dumas G. Effects of Pasteurella multocida toxin on the osteoclast population of the rat. J. Comp. Pathol. 1993, 108:81-91.
103. Masuda M., Minami M., Shime H., Matsuzawa T., Horiguchi Y. In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin. Infect. Immun. 2002, 70:998-1001.
104. Matsuzawa T., Kashimoto T., Katahira J., Horiguchi Y. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin. Infect. Immun. 2002, 70:3427-3432.
105. May B.J., Zhang Q., Li L.L., Paustian M.L., Whittam T.S., Kapur V. Complete genomic sequence of Pasteurella multocida, Pm70. Proc. Natl. Acad. Sci. USA 2001, 98:3460-3465.
106. + current in atrial myocytes. J. Biol. Chem. 2001, 276:5650-5658.
107. Meysick K.C., Mills M., O'Brien A.D. Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli. Infect. Immun. 2001, 69:2066-2074.
108. Mullan P.B., Lax A.J. Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect. Immun. 1996, 64:959-965.
109. Mullan P.B., Lax A.J. Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts. Calcif. Tissue Int. 1998, 63:340-345.
110. Murphy A.C., Rozengurt E. Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein. J. Biol. Chem. 1992, 267:25296-25303.
111. Nakai T., Kume K. Purification of three fragments of the dermonecrotic toxin from Pasteurella multocida. Res. Vet. Sci. 1987, 42:232-237.
112. Nakai T., Kume K., Yoshikawa H., Oyamada T., Yoshikawa T. Changes in the nasal mucosa of specific pathogen-free neonatal pigs infected with Pasteurella multocida or Bordetella bronchiseptica. Nippon Juigaku Zasshi-Jap. J. Vet. Sci. 1986, 48:693-701.
113. Nakai T., Sawata A., Kume K. Intracellular locations of dermonecrotic toxins in Pasteurella multocida and in Bordetella bronchiseptica. Am. J. Vet. Res. 1985, 46:870-874.
114. Nakai T., Sawata A., Tsuji M., Kume K. Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida. Am. J. Vet. Res. 1984, 45:2410-2413.
115. Nakai T., Sawata A., Tsuji M., Samejima Y., Kume K. Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D. Infect. Immun. 1984, 46:429-434.
116. Nielsen J.P., Foged N.T., Sorensen V., Barfod K., Bording A., Petersen S.K. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative. Can. J. Vet. Res. 1991, 55:128-138.
117. Nielsen J.P., Rosdahl V.T. Development and epidemiological applications of a bacteriophage typing system for typing Pasteurella multocida. J. Clin. Microbiol. 1990, 28:103-107.
118. Ohnishi T., Horiguchi Y., Masuda M., Sugimoto N., Matsuda M. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. J. Vet. Med. Sci. 1998, 60:301-305.
119. Okada Y., Fujiyama R., Miyamoto T., Sato T. Saccharin activates cation conductance via inositol 1,4,5-trisphosphate production in a subset of isolated rod taste cells in the frog. Eur. J. Neurosci. 2001, 13:308-314.
120. Orth J.H., Blocker D., Aktories K. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin. Biochem. 2003, 42:4971-4977.
121. q. J. Biol. Chem. 2004, 279:34150-34155.
122. Oswald E., Sugai M., Labigne A., Wu H.C., Fiorentini C., Boquet P., O'Brien A.D. Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc. Natl. Acad. Sci. USA 1994, 91:3814-3818.
123. Pedersen K.B., Barfod K. The etiological significance of Bordetella bronchiseptica and Pasteurella multocida in atrophic rhinitis of swine. Nordisk Veterinaermedicin 1981, 33:513-522.
124. Pedersen K.B., Barford K. Effect on the incidence of atrophic rhinitis of vaccination of sows with a vaccine containing Pasteurella multocida toxin. Nordisk Veterinaermedicin 1982, 34:293-302.
125. Pedersen K.B., Elling F. The pathogenesis of atrophic rhinitis in pigs induced by toxigenic Pasteurella multocida. J. Comp. Pathol. 1984, 94:203-214.
126. Pedersen K.B., Nielsen J.P., Foged N.T., Elling F., Nielsen N.C., Willeberg P. Atrophic rhinitis in pigs: proposal for a revised definition. Vet. Record 1988, 122:190-191.
127. Pei S., Doye A., Boquet P. Mutation of specific acidic residues of the CNF1 T domain into lysine alters cell membrane translocation of the toxin. Mol. Microbiol. 2001, 41:1237-1247.
128. Pennings A.M., Storm P.K. A test in vero cell monolayers for toxin production by strains of Pasteurella multocida isolated from pigs suspected of having atrophic rhinitis. Vet. Microbiol. 1984, 9:503-508.
129. Petersen S.K. The complete nucleotide sequence of the Pasteurella multocida toxin gene and evidence for a transcriptional repressor, TxaR. Mol. Microbiol. 1990, 4:821-830.
130. Petersen S.K., Foged N.T. Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli. Infect. Immun. 1989, 57:3907-3913.
131. Petersen S.K., Foged N.T., Bording A., Nielsen J.P., Riemann H.K., Frandsen P.L. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis. Infect. Immun. 1991, 59:1387-1393.
132. Pettit R.K., Ackermann M.R., Rimler R.B. Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells. Lab. Invest. 1993, 69:94-100.
133. Pettit R.K., Rimler R.B., Ackermann M.R. Protection of Pasteurella multocida dermonecrotic toxin-challenged rats by toxoid-induced antibody. Vet. Microbiol. 1993, 34:167-173.
134. Pullinger G.D., Adams T.E., Mullan P.B., Garrod T.I., Lax A.J. Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp. Infect. Immun. 1996, 64:4163-4171.
135. Pullinger G.D., Bevir T., Lax A.J. The Pasteurella multocida toxin is encoded within a lysogenic bacteriophage. Mol. Microbiol. 2004, 51:255-269.
136. Pullinger G.D., Sowdhamini R., Lax A.J. Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect. Immun. 2001, 69:7839-7850.
137. Rajeev S., Nair R.V., Kania S.A., Bemis D.A. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica. Vet. Microbiol. 2003, 94:313-323.
138. Riising H.J., van Empel P., Witvliet M. Protection of piglets against atrophic rhinitis by vaccinating the sow with a vaccine against Pasteurella multocida and Bordetella bronchiseptica. Vet. Record 2002, 150:569-571.
139. Roop R.M., Veit H.P., Sinsky R.J., Veit S.P., Hewlett E.L., Kornegay E.T. Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect. Immun. 1987, 55:217-222.
140. Rosendal S., Frandsen P.L., Nielsen J.P., Gallily R. Pasteurella multocida toxin induces IL-6, but not IL-1α or TNFα in fibroblasts. Can. J. Vet. Res. 1995, 59:154-156.
141. Rozengurt E., Higgins T., Chanter N., Lax A.J., Staddon J.M. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. USA 1990, 87:123-127.
142. Rutter J.M. Quantitative observations on Bordetella bronchiseptica infection in atrophic rhinitis of pigs. Vet. Record 1981, 108:451-454.
143. Rutter J.M. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica. Res. Vet. Sci. 1983, 34:287-295.
144. Rutter J.M. Atrophic rhinitis in swine. Adv. Vet. Sci. Comp. Med. 1985, 29:239-279.
145. Rutter J.M., Francis L.M., Sansom B.F. Virulence of Bordetella bronchiseptica from pigs with or without atrophic rhinitis. J. Med. Microbiol. 1982, 15:105-116.
146. Rutter J.M., Luther P.D. Cell culture assay for toxigenic Pasteurella multocida from atrophic rhinitis of pigs. Vet. Record 1984, 114:393-396.
147. Rutter J.M., Mackenzie A. Pathogenesis of atrophic rhinitis in pigs: a new perspective. Vet. Record 1984, 114:89-90.
148. Rutter J.M., Taylor R.J., Crighton W.G., Robertson I.B., Benson J.A. Epidemiological study of Pasteurella multocida and Bordetella bronchiseptica in atrophic rhinitis. Vet. Record 1984, 115:615-619.
149. Sabri A., Pak E., Alcott S.A., Wilson B.A., Steinberg S.F. Coupling function of endogenous alpha(1)- and beta-adrenergic receptors in mouse cardiomyocytes. Circ. Res. 2000, 86:1047-1053.
150. q agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ. Res. 2002, 90:850-857.
151. Sah V.P., Seasholtz T.M., Sagi S.A., Brown J.H. The role of Rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharmacol. Toxicol. 2000, 40:459-489.
152. Sakano T., Okada M., Taneda A., Mukai T., Sato S. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type A P. multocida. J. Vet. Med. Sci. 1997, 59:55-57.
153. Sakano T., Taneda A., Okada M., Ono M., Hayashi Y., Sato S. Toxigenic type A Pasteurella multocida as a causative agent of nasal turbinate atrophy in swine. J. Vet. Med. Sci. 1992, 54:403-407.
154. Schmidt G., Goehring U.M., Schirmer J., Uttenweiler-Joseph S., Wilm M., Lohmann M., Giese A., Schmalzing G., Aktories K. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect. Immun. 2001, 69:7663-7670.
155. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 1997, 387:725-729.
156. Schmidt G., Selzer J., Lerm M., Aktories K. The Rhodeamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J. Biol. Chem. 1998, 273:13669-13674.
157. q/11-dependent transactivation of the epidermal growth factor receptor. J. Biol. Chem. 2000, 275:2239-2245.
158. Shime H., Ohnishi T., Nagao K., Oka K., Takao T., Horiguchi Y. Association of Pasteurella multocida toxin with vimentin. Infect. Immun. 2002, 70:6460-6463.
159. q/11 with the insulin receptor in membrane vesicles. Biochem. Biophys. Res. Comm. 2002, 295:561-569.
160. Smyth M.G., Pickersgill R.W., Lax A.J. The potent mitogen Pasteurella multocida toxin is highly resistant to proteolysis but becomes susceptible at lysosomal pH. FEBS Lett. 1995, 360:62-66.
161. Smyth M.G., Sumner I.G., Lax A.J. Reduced pH causes structural changes in the potent mitogenic toxin of Pasteurella multocida. FEMS Microbiol. Lett. 1999, 180:15-20.
162. 2+ in Swiss 3T3 cells. J. Biol. Chem. 1991, 266:4840-4847.
163. Staddon J.M., Bouzyk M.M., Rozengurt E. A novel approach to detect toxin-catalyzed ADP-ribosylation in intact cells: its use to study the action of Pasteurella multocida toxin. J. Cell Biol. 1991, 115:949-958.
164. Staddon J.M., Chanter N., Lax A.J., Higgins T.E., Rozengurt E. Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J. Biol. Chem. 1990, 265:11841-11848.
165. Sterner-Kock A., Lanske B., Uberschar S., Atkinson M.J. Effects of the Pasteurella multocida toxin on osteoblastic cells in vitro. Vet. Pathol. 1995, 32:274-279.
166. Suckow M.A. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine. Lab. Animals 2000, 34:403-408.
167. Suckow M.A., Bowersock T.L., Nielsen K., Chrisp C.E., Frandsen P.L., Janovitz E.B. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits. Lab. Animal Sci. 1995, 45:526-532.
168. Suckow M.A., Chrisp C.E., Foged N.T. Heat-labile, toxin-producing isolates of Pasteurella multocida from rabbits. Lab. Animal Sci. 1991, 41:151-156.
169. Switzer W.P. Studies on infectious atrophic rhinitis. V. Concept that several agents may cause turbinate atrophy. Am. J. Vet. Res. 1956, 17:478-484.
170. Thomas W., Pullinger G.D., Lax A.J., Rozengurt E. Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infect. Immun. 2001, 69:5931-5935.
171. Thurston J.R., Rimler R.B., Ackermann M.R., Cheville N.F. Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D. Vet. Immunol. Immunopathol. 1992, 33:155-162.
172. Thurston J.R., Rimler R.B., Ackermann M.R., Cheville N.F., Sacks J.M. Immunity induced in rats vaccinated with toxoid prepared from heat-labile toxin produced by Pasteurella multocida serogroup D. Vet. Microbiol. 1991, 27:169-174.
173. Tornoe N., Nielsen N.C. Inoculation experiments with Bordetella bronchiseptica strains in SPF pigs. Nordisk Veterinaermedicin 1976, 28:233-242.
174. q/11. Oncogene 1999, 18:7399-7402.
175. q/11 through tyrosine phosphorylation of the α subunit. Science 1997, 276:1878-1881.
176. van Diemen P.M., de Jong M.F., de Vries Reilingh G., van der Hel P., Schrama J.W. Intranasal administration of Pasteurella multocida toxin in a challenge-exposure model used to induce subclinical signs of atrophic rhinitis in pigs. Am. J. Vet. Res. 1994, 55:49-54.
177. van Diemen P.M., de Vries Reilingh G., Parmentier H.K. Immune responses of piglets to Pasteurella multocida toxin and toxoid. Vet. Immunol. Immunopathol. 1994, 41:307-321.
178. van Diemen P.M., de Vries Reilingh G., Parmentier H.K. Effect of Pasteurella multocida toxin on in vivo immune responses in piglets. Vet. Quarterly 1996, 18:141-146.
179. 11. J. Biol. Chem. 2003, 278:28743-28749.
180. Walker K.E., Weiss A.A. Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect. Immun. 1994, 62:3817-3828.
181. Ward P.N., Higgins T.E., Murphy A.C., Mullan P.B., Rozengurt E., Lax A.J. Mutation of a putative ADP-ribosylation motif in the Pasteurella multocida toxin does not affect mitogenic activity. FEBS Lett. 1994, 342:81-84.
182. Ward P.N., Miles A.J., Sumner I.G., Thomas L.H., Lax A.J. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect. Immun. 1998, 66:5636-5642.
183. Wilson B.A., Aminova L.R., Ponferrada V.G., Ho M. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect. Immun. 2000, 68:4531-4538.
184. Wilson B.A., Ponferrada V.G., Vallance J.E., Ho M. Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus. Infect. Immun. 1999, 67:80-87.
185. qα-coupled phospholipase C&1. J. Biol. Chem. 1997, 272:1268-1275.
186. Wu D., Katz A., Simon M.I. Activation of phospholipase C β2 by the α and βγ subunits of trimeric GTP-binding protein. Proc. Natl. Acad. Sci. USA 1993, 90:5297-5301.
187. Zimmerman T.E., Deeb B.J., DiGiacomo R.F. Polypeptides associated with Pasteurella multocida infection in rabbits. Am. J. Vet. Res. 1992, 53:1108-1112.
188. 11. J. Biol. Chem. 2001, 276:3840-3845.